Document Detail

Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia.
MedLine Citation:
PMID:  21489839     Owner:  NLM     Status:  Publisher    
This study evaluated the oxidative stress and antioxidant capacity markers in sickle cell anemia (SCA) patients with and without treatment with hydroxyurea. We assessed GSTT1, GSTM1 and GSTP1 polymorphisms in patients and a control group. The study groups were composed of 48 subjects without hemoglobinopathies and 28 SCA patients, 13 treated with HU [SCA (+HU)], and 15 SCA patients not treated with HU [SCA (-HU)]. We observed a significant difference for GSTP1 polymorphisms in SCA patients with the V/V genotype that showed higher glutathione (GSH) and Trolox equivalent antioxidant capacity (TEAC) (p=0.0445 and p=0.0360), respectively, compared with the I/I genotype. HU use was associated with a 35.2% decrease in the lipid peroxidation levels of the SCA (+HU) group (p<0.0001). Moreover, the SCA (+HU) group showed higher TEAC as compared to the control group (p=0.002). We did not find any significant difference in glutathione-S-transferase (GST) activity between the groups (p=0.76), but the catalase (CAT) activity was about 17% and 30% decreased in the SCA (+HU) and SCA (-HU) groups, respectively (p<0.00001). Whereas the plasma GSH levels were ~2 times higher in the SCA patients than the control group (p=0.0005). HU use has contributed to higher CAT activity and TEAC, and lower lipid peroxidation in patients under treatment. These findings may explain the influence of HU in ameliorating oxidative stress on SCA subjects.
Danilo Grünig Humberto Silva; Edis Belini Junior; Lidiane de Souza Torres; Octávio Ricci Júnior; Clarisse de Castro Lobo; Claudia Regina Bonini-Domingos; Eduardo Alves de Almeida
Related Documents :
18562979 - Il-6 and il-18 in blood may discriminate cirrhotic patients with and without minimal he...
17012299 - Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome.
6605119 - Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis.
17268399 - Linkage of elevated caxpo4 product with inflammation in maintenance hemodialysis patients.
18426269 - Clinical implications of systemic inflammatory response syndrome following thoracic aor...
7987859 - Circulating concentrations of interleukin-6 in cancer patients and their pathogenic rol...
1655589 - Pupillary response to topical naloxone in cluster headache.
15017119 - Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients.
21846359 - Ccr5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a co...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-11
Journal Detail:
Title:  Blood cells, molecules & diseases     Volume:  -     ISSN:  1096-0961     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9509932     Medline TA:  Blood Cells Mol Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
UNESP-Sao Paulo State University, Department of Biology, Hemoglobin and Hematologic Genetic Diseases Laboratory, Sao Paulo, Brazil; UNESP-Sao Paulo State University, Department of Chemistry and Environmental Sciences, Sao Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the ...
Next Document:  Effects of endotoxin and influence of cyclooxygenase-2 on ?-adrenergic mediated relaxation in isolat...